Sy Egco, Jose .

HRN: 28-77-71  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/03/2026
05/10/2026
IV
2.25g
Q8
CAP HR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines